NO20031377D0 - Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese - Google Patents

Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese

Info

Publication number
NO20031377D0
NO20031377D0 NO20031377A NO20031377A NO20031377D0 NO 20031377 D0 NO20031377 D0 NO 20031377D0 NO 20031377 A NO20031377 A NO 20031377A NO 20031377 A NO20031377 A NO 20031377A NO 20031377 D0 NO20031377 D0 NO 20031377D0
Authority
NO
Norway
Prior art keywords
angiogenesis
preparation
activator
inhibitor
processes
Prior art date
Application number
NO20031377A
Other languages
English (en)
Other versions
NO20031377L (no
Inventor
Andreas Bikfalvi
Gerard Deleris
Natacha Betz
Original Assignee
Univ Bordeaux 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bordeaux 1 filed Critical Univ Bordeaux 1
Publication of NO20031377D0 publication Critical patent/NO20031377D0/no
Publication of NO20031377L publication Critical patent/NO20031377L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
NO20031377A 2000-10-04 2003-03-26 Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese NO20031377L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012654A FR2814744B1 (fr) 2000-10-04 2000-10-04 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
PCT/FR2001/003049 WO2002028895A2 (fr) 2000-10-04 2001-10-02 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese

Publications (2)

Publication Number Publication Date
NO20031377D0 true NO20031377D0 (no) 2003-03-26
NO20031377L NO20031377L (no) 2003-05-02

Family

ID=8854977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031377A NO20031377L (no) 2000-10-04 2003-03-26 Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese

Country Status (15)

Country Link
US (2) US7199100B2 (no)
EP (1) EP1328546B1 (no)
JP (1) JP4303958B2 (no)
AT (1) ATE354589T1 (no)
AU (2) AU2001293948B2 (no)
CA (1) CA2424506A1 (no)
DE (1) DE60126802T2 (no)
DK (1) DK1328546T3 (no)
ES (1) ES2282293T3 (no)
FR (1) FR2814744B1 (no)
IL (1) IL155117A0 (no)
NO (1) NO20031377L (no)
NZ (1) NZ525069A (no)
RU (1) RU2249599C2 (no)
WO (1) WO2002028895A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
CA2513044A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
PT2949658T (pt) * 2003-03-03 2018-10-18 Bracco Suisse Sa Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos
DK1979370T3 (da) * 2006-01-17 2010-06-28 Organon Nv Selektiv enzymatisk hydrolyse af C-terminale tert-butyl-ester peptider
JP5186632B2 (ja) 2006-10-19 2013-04-17 ブリッタ ハーディ， 血管形成を誘導するための組成物および方法
US8741850B2 (en) 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
FR2969999B1 (fr) 2011-01-03 2013-02-08 Commissariat Energie Atomique Conjugue, son procede de preparation et ses utilisations
JP6758022B2 (ja) * 2012-09-03 2020-09-23 国立大学法人 東京大学 血管内皮細胞増殖因子受容体阻害ペプチド
CN103724290B (zh) * 2013-11-15 2015-04-29 浙江大学 一种环肽化合物clavatustide A及其产生菌、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5939383A (en) * 1996-11-15 1999-08-17 Remacle; Jose Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
CA2320339A1 (en) * 1998-02-11 1999-08-19 Resolution Pharmaceuticals Inc. Angiogenesis targeting molecules
AU776473C (en) * 1999-03-11 2005-04-14 Entremed, Inc Compositions and methods for treating cancer and hyperproliferative disorders

Also Published As

Publication number Publication date
DE60126802D1 (de) 2007-04-05
US20040092434A1 (en) 2004-05-13
WO2002028895A3 (fr) 2002-06-06
IL155117A0 (en) 2003-10-31
EP1328546B1 (fr) 2007-02-21
FR2814744A1 (fr) 2002-04-05
US7199100B2 (en) 2007-04-03
JP2004510784A (ja) 2004-04-08
RU2249599C2 (ru) 2005-04-10
NO20031377L (no) 2003-05-02
EP1328546A2 (fr) 2003-07-23
AU2001293948B2 (en) 2005-11-03
ATE354589T1 (de) 2007-03-15
DE60126802T2 (de) 2007-11-08
JP4303958B2 (ja) 2009-07-29
AU9394801A (en) 2002-04-15
ES2282293T3 (es) 2007-10-16
WO2002028895A2 (fr) 2002-04-11
DK1328546T3 (da) 2007-06-04
FR2814744B1 (fr) 2002-11-29
NZ525069A (en) 2004-09-24
CA2424506A1 (en) 2002-04-11
USRE44022E1 (en) 2013-02-19

Similar Documents

Publication Publication Date Title
NO20031377D0 (no) Sykliske peptider, fremgangsmåte for fremstilling av slike og anvendelse som inhibitor eller aktivator av angiogenese
EE05485B1 (et) Plasmi(i)n(ogeen)i eemaldamine valgulahustest
DK1210430T3 (da) MUC-1-afledte peptider
CO5590973A2 (es) Acido nucleico de adenovirus de simio y secuiencias de aminoacidos, vectores que contienen los mismos y metodos de uso
ES2721172T3 (es) Una nueva clase de moléculas terapéuticas a base de proteínas
SE9300140D0 (sv) Solid substrate
NO20070618L (no) Forbindelser og fremgangsmater for immunterapi og diagnose av tuberkulose.
DE69739035D1 (de) Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen
ES2046237T3 (es) Acidos boronicos peptidos inhibidores de proteasas de tipo tripsinico.
HUP0300246A2 (en) Delivery system
PT1165115E (pt) Modulacao da permeabilidade vascular por meio dos activadores do receptor tie2
Inokuchi et al. Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme)
NO960939L (no) Kininogenaseinhibitor
NO20055210L (no) Inhibitorproteiner av en protease og anvendelse derav
DE69627191D1 (de) Bradikininanaloge als selektive thrombininhibitoren
DE60027030D1 (de) Membrantranslokierendes peptid als wirkstofftransportsystem
DK1024822T3 (da) CD8 som inhibitor for det cellulære immunsystem
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
DK0918865T3 (da) Immunologisk aktive proteiner af Borrelia burgdorferi, derfor kodende nukleinsyrer samt deres anvendelse i testkits og som vacciner
WO2001004283A3 (en) Organic anion transporter genes and proteins
CO5271650A1 (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia
NO951277L (no) Desulfatohirudin med höy molekylvekt
Needleman et al. Sequencing peptides and proteins lacking free α-amino groups
WO2000035407A3 (en) Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
ATE401408T1 (de) Tapetum-spezifische promotoren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application